Filing Flows › Cannapharmarx (CPMD) › Q4 2025
Cannapharmarx (CPMD) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Mar 31, 2026
Cannapharmarx (CPMD) reported revenue of $139K for the fourth quarter 2025 (Q4 2025), -71% from a year earlier and -79% from the quarter before. Operating margin was -644.6%.
Cannapharmarx, Q4 2025: revenue $139K (-71% year over year), operating margin -644.6%, net loss $7.5M, operating cash flow $1.1M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $139K | -79% | -71% |
| Operating profit | −$894K | — | — |
| Net earnings | −$7.5M | — | — |
| Operating cash flow | $1.1M | — | — |
What changed
Revenue was $139K in Q4 2025, down 71% year over year and down 79% from the previous quarter.
Operating costs exceeded revenue by $894K, an operating margin of -644.6%. Total costs fell 49% while revenue fell 71%. The quarter ended with a net loss of $7.5M, wider than the previous quarter's $1.5M loss. Net interest and other expense of $6.7M was the main reason.
Operating cash flow was $1.1M. Working capital and other items added $8.6M.
Questions
What was Cannapharmarx's revenue in the fourth quarter 2025?
Cannapharmarx (CPMD) reported revenue of $139K for the fourth quarter 2025 (Q4 2025), -71% from a year earlier and -79% from the quarter before.
Was Cannapharmarx profitable in the fourth quarter 2025?
Operating loss was $894K (-644.6% of revenue) and net loss $7.5M.
Source: Cannapharmarx 10-K on SEC EDGAR.